584 related articles for article (PubMed ID: 12912938)
41. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
42. c-Kit expression in patients with uterine leiomyosarcomas: a potential alternative therapeutic treatment.
Raspollini MR; Amunni G; Villanucci A; Pinzani P; Simi L; Paglierani M; Taddei GL
Clin Cancer Res; 2004 May; 10(10):3500-3. PubMed ID: 15161707
[TBL] [Abstract][Full Text] [Related]
43. p53 gene mutations and p53 protein expression in human soft tissue sarcomas.
Yoo J; Lee HK; Kang CS; Park WS; Lee JY; Shim SI
Arch Pathol Lab Med; 1997 Apr; 121(4):395-9. PubMed ID: 9140310
[TBL] [Abstract][Full Text] [Related]
44. Classification of canine nonangiogenic, nonlymphogenic, gastrointestinal sarcomas based on microscopic, immunohistochemical, and molecular characteristics.
Hayes S; Yuzbasiyan-Gurkan V; Gregory-Bryson E; Kiupel M
Vet Pathol; 2013 Sep; 50(5):779-88. PubMed ID: 23456969
[TBL] [Abstract][Full Text] [Related]
45. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
[TBL] [Abstract][Full Text] [Related]
46. The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST).
Du CY; Shi YQ; Zhou Y; Fu H; Zhao G
J Surg Oncol; 2008 Sep; 98(3):175-8. PubMed ID: 18618605
[TBL] [Abstract][Full Text] [Related]
47. Multifocality and multifocal postradiation sarcomas.
Holt GE; Thomson AB; Griffin AM; Bell R; Wunder J; Rougraff B; Schwartz HS
Clin Orthop Relat Res; 2006 Sep; 450():67-75. PubMed ID: 16906076
[TBL] [Abstract][Full Text] [Related]
48. [Histopathological diagnostic concordance in bone and soft tissue sarcomas between two comprehensive cancer centers from eastern and western Europe: a collaborative experience].
Somcutian O; Buiga R; Galatir M; Tudor Eniu D; Rachieru C; Coza D; Terrier P
Ann Pathol; 2015 Jan; 35(1):32-40. PubMed ID: 25541117
[TBL] [Abstract][Full Text] [Related]
49. Long-term risk of sarcoma following radiation treatment for breast cancer.
Taghian A; de Vathaire F; Terrier P; Le M; Auquier A; Mouriesse H; Grimaud E; Sarrazin D; Tubiana M
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):361-7. PubMed ID: 1648044
[TBL] [Abstract][Full Text] [Related]
50. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
[TBL] [Abstract][Full Text] [Related]
51. [Radiation-induced sarcoma after breast cancer. Apropos of 8 cases and review of the literature].
Kirova YM; Feuilhade F; Calitchi E; Otmezguine Y; Bélembaogo E; Le Bourgeois JP
Cancer Radiother; 1998; 2(4):381-6. PubMed ID: 9755752
[TBL] [Abstract][Full Text] [Related]
52. Immunohistochemical evaluation of KIT expression in sarcomas of the gynecologic region.
Nakayama M; Mitsuhashi T; Shimizu Y; Ban S; Ogawa F; Ishihara O; Shimizu M
Int J Gynecol Pathol; 2006 Jan; 25(1):70-6. PubMed ID: 16306788
[TBL] [Abstract][Full Text] [Related]
53. From morphological to molecular diagnosis of soft tissue tumors.
Miettinen M
Adv Exp Med Biol; 2006; 587():99-113. PubMed ID: 17163160
[TBL] [Abstract][Full Text] [Related]
54. Postradiation osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients.
Huvos AG; Woodard HQ; Cahan WG; Higinbotham NL; Stewart FW; Butler A; Bretsky SS
Cancer; 1985 Mar; 55(6):1244-55. PubMed ID: 3855683
[TBL] [Abstract][Full Text] [Related]
55. MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.
Schmitz K; Koeppen H; Binot E; Fassunke J; Künstlinger H; Ihle MA; Heydt C; Wardelmann E; Büttner R; Merkelbach-Bruse S; Rüschoff J; Schildhaus HU
PLoS One; 2015; 10(4):e0120079. PubMed ID: 25844809
[TBL] [Abstract][Full Text] [Related]
56. [Diagnostic application of immunohistochemistry in pleomorphic sarcomas].
Lin JS
Zhonghua Bing Li Xue Za Zhi; 1990 Mar; 19(1):67-70. PubMed ID: 2166629
[TBL] [Abstract][Full Text] [Related]
57. Postradiation sarcomas of bone.
Huvos AG; Woodard HQ
Health Phys; 1988 Oct; 55(4):631-6. PubMed ID: 2844696
[TBL] [Abstract][Full Text] [Related]
58. [Prognosis of post-irradiation soft-tissue sarcoma: case-control study].
Leclercq C; Penel N; Grosjean J; Fournier C; Vilain MO; Pasquier D; Ceugnart L; Vanseymortier L
Rev Med Interne; 2004 Dec; 25(12):866-71. PubMed ID: 15582166
[TBL] [Abstract][Full Text] [Related]
59. The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group.
Perrier L; Rascle P; Morelle M; Toulmonde M; Ranchere Vince D; Le Cesne A; Terrier P; Neuville A; Meeus P; Farsi F; Ducimetière F; Blay JY; Ray Coquard I; Coindre JM
PLoS One; 2018; 13(4):e0193330. PubMed ID: 29621244
[TBL] [Abstract][Full Text] [Related]
60. Postradiation sarcoma after radiotherapy for nasopharyngeal carcinoma.
Chan JY; Wong ST; Lau GI; Wei WI
Laryngoscope; 2012 Dec; 122(12):2695-9. PubMed ID: 23070724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
